Andrew R. Conery

Targeting MYC dependence in cancer by inhibiting BET bromodomains

Jennifer A. Mertz, Andrew R. Conery, Barbara M. Bryant et al. · Proceedings of the National Academy of Sciences · 2011 · 1.1K citations · Full text

Myc Transcript, Chromatin, Transcriptional Regulation +15

Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β-induced apoptosis

Andrew R. Conery, Yanna Cao, E. Aubrey Thompson et al. · Nature Cell Biology · 2004 · 389 citations

Signal Transduction, Molecular Physiology, Signaling Pathway +8

A kinase shRNA screen links LATS2 and the pRB tumor suppressor

Katrin Tschöp, Andrew R. Conery, Larisa Litovchick et al. · Genes & Development · 2011 · 123 citations · Full text

Systems Biology, Signal Transduction, Cell Regulation +13

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma

Andrew R. Conery, Richard C. Centore, Adrianne Neiss et al. · eLife · 2016 · 118 citations · Full text

Hematological Malignancy, Bromodomain Inhibition, Malignant Blood Disorder +9

Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)

Alexander M. Taylor, Alexandre Côté, Michael C. Hewitt et al. · ACS Medicinal Chemistry Letters · 2016 · 111 citations · Full text

Drug Target, Chemical Biology, Cancer Biology +16